Business
ValiRx to exhibit and present at the AACR
ValiRx to exhibit and present at the AACR.
About this update from Valirx Plc
[{"type":"text","content":"\n \nRNS Number : 6084T ValiRx PLC 31 March 2016 \n\nValiRx Plc\n(\"ValiRx\" or \"the Company\")\n \nValiRx is exhibiting and presenting at the prestigious AACR\n \nLondon, UK, 31st March 2016: ValiRx Plc (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, will be presenting its collaborative research at the American Association for Cancer Research Annual Conference in New Orleans starting on April 16th 2016. The Conference is an annual event designed to showcase and bring together developments in all major areas of cancer research. There were nearly 20,000 participants in attendance last year.\n \nValiRx therapeutics and diagnostics are further exhibiting and promoting its products, therapeutics and services to the wider participating oncology community, including the individual researcher up to multinational research and pharmaceutical organisations, many of whom are attending the conference. The profile of the exhibition and the promotion of the presentations will be supported by Burns McClellan, the leading US-based consultancy, who will assist in making wider connections while the Company concentrates on strengthening its current relationships. Valirx will also be using the opportunity to promote the excellent results being seen in the clinical trial for VAL201.\n \nSatu Vainikka, Chief Executive of ValiRx, commented: \"This is another great opportunity for us to show the excellence of our technology and products in a large international arena.\"\n \n*** ENDS ***\n \nFor more information, please contact:\n \n\n\n\n\nValiRx plc\n\n\nTel: +44 (0) 20 3008 4416\nwww.valirx.com\n\n\n\n\nDr Satu Vainikka, Chief Executive\n\n\nTel: +44 (0) 20 3008 4416\n\n\n\n\nTarquin Edwards, Head of Communications.\n\n\nTel: +44 (0) 7879 458 364\[email protected]\n\n\n\n\nMark Treharne, Corporate Development Manager\n\n\nTel: +44 (0) 7736 564 686\[email protected]\n\n\n\n\n\n\n\n\n\n\n\n\nNorthland Capital Partners Limited (Broker)\n\n\nTel: +44 (0) 20 7382 1100\n\n\n\n\nPatrick Claridge / David Hignell (Corporate Finance)\nJohn Howes / Abigail Wayne (Broking)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \nAbout ValiRx Plc \nValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncolo...